Pfizer Inc. (NYSE:PFE) is included among the 12 Best Dividend Paying Stocks to Buy Now.
Pfizer Inc. (NYSE:PFE) ranks among the world’s top pharmaceutical companies, with vast resources to back its research and development efforts. Still, the process of discovering, testing, and getting approval for new drugs is complex, time-intensive, and carries no guarantees, no matter how much funding is committed.
In the second quarter, Pfizer Inc. (NYSE:PFE) reported a 10% year-over-year rise in revenue and a 30% jump in earnings per share. Management emphasized its confidence in execution, highlighting that full-year 2025 adjusted diluted EPS guidance was raised to reflect the company’s ability to deliver on strategic priorities and generate solid returns for shareholders.
Moreover, Pfizer Inc. (NYSE:PFE) has always grabbed income investors’ attention because of its solid dividend history. The company has been growing its dividends for 25 years in a row and offers a quarterly dividend of $0.43 per share. With a dividend yield of 7.16%, as of September 19, PFE is among the best dividend paying stocks.
While we acknowledge the potential of PFE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 13 Best Consistent Dividend Stocks to Buy Now and Dividend Stock Portfolio For Income: 12 Stocks to Buy Now.
Disclosure: None.